Although studies on prostate cancer can reveal the prognostic and therapeutic importance of survivin, further studies on survivin level in different cancers would make a valuable therapeutic and prognostic target for treating patients with other cancers, as well. This evidence concerns the gene BIRC5 and Familial prostate cancer.